The Economic Burden of Migraine to Society
- Dr Michel D. Ferrari
- … show all 1 hide
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
The financial burden of migraine on society comprises direct costs, associated with medical care, and indirect costs, caused by absence from work and reduced productivity.
Recent studies have revealed that direct costs are generally relatively low in Europe, but are much higher in North America, probably because of increased use of emergency room and specialist consultations for the treatment of migraine. Most individuals who experience migraine headaches take medication (over-thecounter, prescription-only or a combination of both) for their condition; in Europe and North America, most patients who experience migraines have consulted a physician at some time because of their condition.
In general, the estimated indirect costs of migraine are substantial and are much higher than estimates of direct costs. On average, work losses related to reduced productivity are higher than those related to work absence. These data demonstrate the importance of the societal impact of migraine and illustrate the need for improved strategies to target migraine treatment.
- Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8Suppl: pp. 19-28
- Edmeads, J, Findlay, H, Tugwell, P (1993) Impact of migraine and tension—type headache on life—style, consulting behaviour, and medication use: a Canadian population survey. Can J Neurol Sci 20: pp. 131-7
- Streator, SE, Shearer, SW (1996) Pharmacoeconomic impact of injectable sumatriptan on migraine-associated healthcare costs. Am J Manage Care 2: pp. 139-43
- Celentano, DD, Stewart, WF, Lipton, RB (1992) Medication use and disability among migraineurs: a national probability sample survey. Headache 32: pp. 223-8 CrossRef
- Osterhaus, JT, Gutterman, DL, Plachetka, JR (1992) Healthcare resource and lost labour costs of migraine headache in the US. Pharmacoeconomics 2: pp. 67-76 CrossRef
- Stang, PE, Osterhaus, JT, Celentano, DD (1994) Migraine: problems of healthcare. Neurology 44Suppl.: pp. S47-55
- Rasmussen, BK, Jensen, R, Olesen, J (1992) Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J Epidemiol Community Health 46: pp. 443-6 CrossRef
- Roijen, L, Essink-Bot, M—L, Koopmanschap, MA (1995) Societal perspective on the burden of migraine in the Netherlands. Pharmacoeconomics 7: pp. 170-9 CrossRef
- Wong, TW, Wong, KS, Yu, TS (1995) Prevalence of migraine and other headaches in Hong Kong. Neuroepidemiology 14: pp. 82-91 CrossRef
- Sakai, F, Igarashi, H (1997) Epidemiology of migraine in Japan: a nationwide study. Cephalalgia 17: pp. 15-22 CrossRef
- Kaa, KA, Carlson, JA, Osterhaus, JT (1995) Emergency department resource use by patients with migraine and asthma in a health maintenance organization. Ann Pharmacother 29: pp. 251-6
- Micieli, G I Migraine: a brighter future. In: Edmeads, J eds. (1993) Worthing: Cambridge Medical Publications. pp. 1-7
- Parry, TG (1992) The prevalence and costs of migraine in Australia. Kensington: University of New South Wales.
- Björk, S, Roos, P (1991) Economic aspects of migraine in Sweden. Lund: Institute for Health Economics.
- Blau, JN, Drummond, MF (1991) Migraine. London: Office of Health Economics.
- Electronic database. New York: LP Bloomberg.
- International financial statistics. Vol. 11 (1). Washington, DC: IMF.
- O’Brien, B, Goeree, R, Streiner, D (1994) Prevalence of migraine headache in Canada: a population-based survey. Int J Epidemiol 23: pp. 1020-6 CrossRef
- Clouse, JC, Osterhaus, JT (1994) Healthcare resource use and costs associated with migraine in a managed healthcare setting. Ann Pharmacother 28: pp. 659-64
- Cull, RE, Wells, NEJ, Miocevich, ML (1992) The economic cost of migraine. Br J Med Econ 2: pp. 103-15
- Láinez, JM, Titus, F, Cobaleda, S (1996) Socioeconomic impact of migraine [abstract]. Funct Neurol 11: pp. 133
- Clarke, CE, MacMillan, L, Sondhi, S (1996) Economic and social impact of migraine. Q J Med 89: pp. 77-84 CrossRef
- Stewart, WF, Lipton, RB, Celentano, DD (1992) Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors. JAMA 267: pp. 64-9 CrossRef
- Stewart, WF, Lipton, RB, Simon, D (1996) Work-related disability: results from the American migraine study. Cephalalgia 16: pp. 231-8 CrossRef
- To, T, Wu, K (1995) Health care utilization and disability of migraine: the Ontario health survey. Can J Public Health 86: pp. 195-9
- Stang, PE, Osterhaus, JT (1993) Impact of migraine in the United States: data from the National Health Interview Survey. Headache 33: pp. 29-35 CrossRef
- Breslau, N, Davis, GC, Andreski, P (1991) Migraine, psychiatric disorders, and suicide attempts: an epidemiologic study of young adults. Psychiatry Res 37: pp. 11-23 CrossRef
- Göbel, H, Petersen-Braun, M (1994) Why patients with primary headaches do not consult a doctor. New York: Raven Press Ltd. pp. 267-72
- Huse, DM, Oster, G, Killen, AR (1989) The economic costs of non-insulin dependent diabetes mellitus. JAMA 262: pp. 2708-13 CrossRef
- Lipton, RB, Stewart, WF, Korff, M (1994) The burden of migraine. Pharmacoeconomics 6: pp. 215-21 CrossRef
- Sawyer, J, Edmeads, J, Lipton, RB (1998) Clinical utility of a new instrument assessing migraine disability: the migraine disability assessment (MIDAS) questionnaire [abstract]. Neurology 50Suppl.: pp. A433-4
- The Economic Burden of Migraine to Society
Volume 13, Issue 6 , pp 667-676
- Cover Date
- Print ISSN
- Online ISSN
- Springer International Publishing
- Additional Links
- Industry Sectors
- Author Affiliations
- 1. Department of Neurology, Leiden University Medical Centre, 2300 RC, Leiden, The Netherlands